<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03434951</url>
  </required_header>
  <id_info>
    <org_study_id>KNEMO 01</org_study_id>
    <nct_id>NCT03434951</nct_id>
  </id_info>
  <brief_title>Intrathecal Morphine and Local Infiltration Analgesia in Total Knee Arthroplasty</brief_title>
  <official_title>Intrathecal Morphine and Local Infiltration Analgesia in Total Knee Arthroplasty, a Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>South Carelia Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>South Carelia Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Double-blinded randomized control study investigating intrathecal morphine as an additive to
      spinal anesthesia in patients undergoing elective total knee arthroplasty. The investigators
      aim to include a total of 120 patients, randomized to two equal groups. Participants in the
      intervention group are administered intrathecal 0,2mg morphine and 12,5mg bupivacaine for
      spinal anaesthesia. Participants in the placebo group are administered 12.5mg bupivacaine and
      saline to match the volume of intervention goup. Primary end points are opioid consumption
      and possible adverse effects.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 6, 2017</start_date>
  <completion_date type="Anticipated">September 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intravenous oxycodone consumption</measure>
    <time_frame>48 hours</time_frame>
    <description>Cumulative postoperative consumption</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse effects of 0,2mg intrathecal morphine</measure>
    <time_frame>48 hours</time_frame>
    <description>Possible nausea, vomiting, itching and respiratory depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mobilization time</measure>
    <time_frame>48 hours</time_frame>
    <description>Assessing the time to ambulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>28 days</time_frame>
    <description>Telephone interview 28 days after surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Intrathecal morphine and bupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0,2mg intrathecal morphine and 12,5mg bupivacaine administered</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12,5mg bupivacaine and NaCl 0,9% to match the same volume administered</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine Hydrochloride, Spinal</intervention_name>
    <description>Intrathecally administered 12,5mg bupivacaine for spinal anaesthesia</description>
    <arm_group_label>Intrathecal morphine and bupivacaine</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine hydrochloride, Spinal</intervention_name>
    <description>Intrathecally administered morphine 0,2mg (2mg/ml, 0,1ml)</description>
    <arm_group_label>Intrathecal morphine and bupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo - Concentrate</intervention_name>
    <description>Intrathecally administered saline solution 0,9% 0,1ml to match morphine volume</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>physiologic saline solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective primary total knee arthroplasty

          -  ASA I-III

          -  written consent

        Exclusion Criteria:

          -  rearthroplasty

          -  ASA IV-V

          -  inadequate spoken finnish for reliable pain assessment

          -  Dementia or otherwise impaired cognition

          -  contraindication for any medication or substance used in survey protocol

          -  weight &lt;50kg or BMI ≥35 kg/m2

          -  preoperative SpO2 less than 93%

          -  clinical suspicion that subject can not use PCA adequately

          -  history of substance abuse or current excessive use of alcohol

          -  preoperative use of either pregabalin, gabapentin or strong opiates
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seppo Mustola, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>South Carelia Central Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Susanna Niinimäki, BSc, SRN /Anesthesia</last_name>
    <phone>+358406511388</phone>
    <email>susanna.niinimaki@eksote.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Seppo Mustola, MD, PhD</last_name>
    <phone>+358447915832</phone>
    <email>seppo.mustola@eksote.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>South Carelia Central Hospital</name>
      <address>
        <city>Lappeenranta</city>
        <zip>53130</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susanna Niinimäki, BSc, SRN /Anesthesia</last_name>
      <phone>+358406511388</phone>
      <email>Susanna.niinimaki@eksote.fi</email>
    </contact>
    <contact_backup>
      <last_name>, MD, PhD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2017</study_first_submitted>
  <study_first_submitted_qc>February 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2018</study_first_posted>
  <last_update_submitted>February 14, 2018</last_update_submitted>
  <last_update_submitted_qc>February 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>South Carelia Central Hospital</investigator_affiliation>
    <investigator_full_name>Susanna Niinimäki</investigator_full_name>
    <investigator_title>SRN/ Anesthesia</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

